Balaji, M. S., and M. Girish. “A Study of Utility of Delta IgG As a Prognostic Marker in Guillain Barre Syndrome After IV Immunoglobulin Treatment”. International Journal of Health Sciences, vol. 6, no. S5, June 2022, pp. 4274-87, doi:10.53730/ijhs.v6nS5.9555.